4th Quarter - Termination

ROCK & ASSOCIATES for BRAIDWOOD MANAGEMENT, INC.

Period 4th Quarter 2024 Filed Feb 2, 2025 Signed by James W. Rock

Official filing
Firm
ROCK & ASSOCIATES
Client
BRAIDWOOD MANAGEMENT, INC.
Income
$6,000
Expenses
—
Terminated
Dec 31, 2024

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Legislation relating to the regulation of compounding pharmacies. No specific legislation at this time.

LobbyistCovered position, as disclosed
JAMES W ROCK —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Pharmacy PHA

Legislation relating to regulation of compounding pharmacies.

LobbyistCovered position, as disclosed
JAMES W ROCK —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Budget/Appropriations BUD

Appropriations legislation related to FDA and compounding pharmacy.

LobbyistCovered position, as disclosed
JAMES W ROCK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.